Baker Bros. Advisors »

Wave Life Sciences shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Wave Life Sciences (WVE) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Wave Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Wave Life Sciences held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Wave Life Sciences by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.8M 344k 8.20

More positions owned by Baker Bros. Advisors

BeiGene Sponsored Adr (BGNE)
Incyte Corporation (INCY)
ACADIA Pharmaceuticals (ACAD)
Summit Therapeutics (SMMT)
Madrigal Pharmaceuticals (MDGL)
Revolution Medicines (RVMD)
Rhythm Pharmaceuticals (RYTM)
Insmed Incorporated Com Par $.01 (INSM)
Kymera Therapeutics (KYMR)
Bicycle Therapeutics Sponsored Ads (BCYC)
Edgewise Therapeutics (EWTX)
Replimune Group (REPL)
Alkermes SHS (ALKS)
Denali Therapeutics (DNLI)
Insmed Incorporated Note 0.75% 6/1/2028 (Principal)

View all positions for Baker Bros. Advisors

Top funds holding Wave Life Sciences

RA Capital Management
Maverick Capital
BlackRock
BlackRock
M28 Capital Management
Driehaus Capital Management
Siren
683 Capital Management
Bellevue Group
Kynam Capital Management
T. Rowe Price Associates
Emerald Advisers
PRIMECAP Management Company
Vanguard Group
Geode Capital Management

View all funds holding Wave Life Sciences